Progyny Logo 2022.png
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
20. März 2023 12:00 ET | Progyny
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced...
Progyny Logo 2022.png
Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
14. März 2023 09:00 ET | Progyny
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the...
Progyny Logo 2022.png
Detroit Pistons Become First Professional Sports Team in the United States to Partner with Progyny to Provide Comprehensive, Value-Based Family Building Care
01. März 2023 09:00 ET | Progyny
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced a...
Progyny Logo 2022.png
Progyny, Inc. Announces Fourth Quarter 2022 Results
27. Februar 2023 16:03 ET | Progyny
Reports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance...
Progyny Logo 2022.png
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report
13. Februar 2023 16:44 ET | Progyny
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its...
Progyny Logo 2022.png
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
09. Januar 2023 08:00 ET | Progyny
Anticipates Results to be at the High-End of its Previously Provided Financial GuidanceAnticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09,...
Progyny Logo 2022.png
Progyny Raises 2022 Financial Guidance
28. November 2022 08:00 ET | Progyny
NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits...
Progyny Logo 2022.png
Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference
04. November 2022 12:00 ET | Progyny
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that...
Progyny Logo 2022.png
Progyny, Inc. Announces Third Quarter 2022 Results
03. November 2022 16:01 ET | Progyny
Receives Record Number of New Client Commitments in Selling SeasonReports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year PeriodRaises Full Year 2022 Guidance,...
Progyny Logo 2022.png
Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report
18. Oktober 2022 13:05 ET | Progyny
NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its...